Seagrove’s Bluebook and Original Research Series cover timely topics within the Cardiovascular, Diabetes and Oncology disease states, offering readers carefully researched and vetted data points and clinical education material.

 

Photo by ratmaner/iStock / Getty Images

Photo by ratmaner/iStock / Getty Images

dIABETES BLUEBOOK ($4,900)

A widely-read publication, the Seagrove Diabetes Blue Book is a statistical almanac of all things diabetes. The Blue Book is updated annually and includes the following sections (total of 204 pages):

  • Disease Overview

  • Epidemiology

  • Domestic Market Statistics

  • Treatment Regimens

  • Automated Insulin Delivery

  • Clinical Trials and Outcomes

  • Company Profiles and Financials

market overview.png

Photo by Ash2016/iStock / Getty Images

Photo by Ash2016/iStock / Getty Images

CARDIOVASCULAR BLUEBOOK ($4,900)

Seagrove’s newest publication, the Seagrove Cardiovascular Blue Book is a statistical almanac the covers general CV topics with specific detail on hyperlipidemia. The Blue Book is updated periodically and includes the following sections (total of 100+ pages):

  • Disease Overview

  • Epidemiology

  • Domestic Market Statistics

  • high cholesterol disease detail

  • drug therapies: statins

  • drug therapies: statin alternatives

  • Company Profiles and Financials

statin trends.png

Photo by Eraxion/iStock / Getty Images

Photo by Eraxion/iStock / Getty Images

LUNG CANCER BLUEBOOK ($4,900)

Seagrove’s next publication, the Seagrove Lung Cancer Blue Book is a statistical almanac the covers general oncology topics with specific detail on lung cancer. The Blue Book is updated periodically and includes the following sections (total of 100+ pages):

  • DISEASE OVERVIEW

  • EPIDEMIOLOGY

  • DOMESTIC MARKET STATISTICS

  • lung cancer disease detail

  • DRUG THERAPIES: chemotherapy

  • DRUG THERAPIES: biologics

  • Research in progress

  • COMPANY PROFILES AND FINANCIALS

 

The Seagrove Original Research Series consists of monthly publications consisting of either secondary or primary research. (prices vary depending upon report)